Health and Financial Notices




NEW ZEALAND GAZETTE, No. 104 — 24 SEPTEMBER 2015

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product:
Prevenar 13

Active Ingredients:
Pneumococcal polysaccharide serotype 6A 2.2mcg
Pneumococcal polysaccharide type 1 2.2mcg
Pneumococcal polysaccharide type 14 2.2mcg
Pneumococcal polysaccharide type 18C 2.2mcg
Pneumococcal polysaccharide type 19A 2.2mcg
Pneumococcal polysaccharide type 19F 2.2mcg
Pneumococcal polysaccharide type 23F 2.2mcg
Pneumococcal polysaccharide type 3 2.2mcg
Pneumococcal polysaccharide type 4 2.2mcg
Pneumococcal polysaccharide type 5 2.2mcg
Pneumococcal polysaccharide type 6B 4.4mcg
Pneumococcal polysaccharide type 7F 2.2mcg
Pneumococcal polysaccharide type 9V 2.2mcg

Dosage Form:
Suspension for injection

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturers:
Pfizer Ireland Pharmaceuticals, Dublin, Ireland
Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, New York, United States of America
Baxter BioPharma Solutions LLC, Indiana, United States of America

Dated this 17th day of September 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2015-go5642

Notice of Determination Regarding Type of Interest in a Foreign Investment Fund and Use of Fair Dividend Rate Method

  1. This is a notice, made under section 91AAO(5) of the Tax Administration Act 1994, of a determination made by the Commissioner of Inland Revenue under section 91AAO(1) of that Act.

  2. Determination FDR 2015/02 was made on 21 September 2015 permitting an investor to use the fair dividend rate method to calculate foreign investment fund income from the Harness Macro Currency Fund for the 2015–2016 and subsequent income years.

  3. The determination will appear in Inland Revenue’s Tax Information Bulletin, Vol. 27, No. 9, of October 2015 and will also be available on the Inland Revenue website:
    www.ird.govt.nz

JOHN TREZISE, Investigations Manager, Investigations and Advice, Inland Revenue.

2015-go5660

Notice Under the Health and Safety in Employment (Pressure Equipment, Cranes, and Passenger Ropeways) Regulations 1999

Pursuant to Regulation 6 of the Health and Safety in Employment (Pressure Equipment, Cranes, and Passenger Ropeways) Regulations 1999 (“the Regulations”), I, Richard Steel, Manager Technical Support Services, WorkSafe New Zealand, in exercise of the powers delegated to me by the Chief Executive of WorkSafe New Zealand, give notice of the following:

55



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2015, No 104





✨ LLM interpretation of page content

🏥 Consent to the Distribution of a New Medicine (continued from previous page)

🏥 Health & Social Welfare
17 September 2015
Medicines, Consent, Prevenar 13, Pneumococcal polysaccharide, Medsafe, Ministry of Health
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

💰 Notice of Determination Regarding Type of Interest in a Foreign Investment Fund and Use of Fair Dividend Rate Method

💰 Finance & Revenue
21 September 2015
Tax Administration, Foreign Investment Fund, Fair Dividend Rate Method, Harness Macro Currency Fund, Inland Revenue
  • JOHN TREZISE, Investigations Manager, Investigations and Advice, Inland Revenue

🏥 Notice Under the Health and Safety in Employment (Pressure Equipment, Cranes, and Passenger Ropeways) Regulations 1999

🏥 Health & Social Welfare
Health and Safety, Pressure Equipment, Cranes, Passenger Ropeways, WorkSafe New Zealand
  • Richard Steel, Manager Technical Support Services, WorkSafe New Zealand